Safety and Efficacy of Subdermal Betadine During Posterior Spinal Fusion
Subdermal Betadine to Reduce Microbacterial Bioburden During Posterior Spinal Fusion
Akron Children's Hospital
60 participants
Jan 3, 2025
INTERVENTIONAL
Conditions
Summary
Bacterial in the subdermal layer of the skin, such as in hair follicles and sweat glands, may contaminate surgical wounds. The goal of this study is to learn about povidone-iodine and its ability to prevent infections specifically in patients with scoliosis receiving a spinal fusion.
Eligibility
Inclusion Criteria3
- Males and females
- Undergoing primary posterior spinal fusion of the thoracic and/or lumbar spine
- English Speaking
Exclusion Criteria3
- Patients who have undergone prior spinal surgery
- Undergoing procedures other than primary posterior spinal fusion of the thoracic and/or lumbar spine (cervical fusion, anterior surgery, growth-friendly instrumentation)
- Any contraindication to povidone-iodine, including pregnancy, allergy, or prior treatment with radioiodine
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A second application of surgical antisepsis with a topical povidone-iodine in the subdermal layer after making an incision.
An application of saline in the subdermal layer after making an incision.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06744907